SD Biosensor KRX:137310KOSPI
에스디바이오센서 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days2
DART filings, 7 days1
Articles tracked19since Sep 11
In Q2 2026, SD Biosensor reported revenue of ₩186bn, up 12.0% year on year, and an operating loss of ₩7.3bn. SD Biosensor (에스디바이오센서) appeared in 2 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 28 with 1 article.
Filing signals 4 quarters of losses Screener
SD Biosensor quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩186bn | +12.0% | −₩7.3bn margin −3.9% | ₩16.3bn |
| Q1 2026 | ₩194bn | +4.4% | −₩11.6bn margin −6.0% | ₩22.3bn |
| Q4 2025 derived | ₩195bn | +8.0% | −₩31.8bn margin −16.4% | −₩760bn |
| Q3 2025 | ₩164bn | -3.8% | −₩14.0bn margin −8.5% | −₩9.9bn |
| Q2 2025 | ₩167bn | -0.6% | −₩20.6bn margin −12.4% | ₩275bn |
| Q1 2025 | ₩185bn | +5.1% | −₩14.6bn margin −7.9% | −₩18.8bn |
| Q4 2024 derived | ₩180bn | +12.8% | −₩18.1bn margin −10.0% | −₩134bn |
| Q3 2024 | ₩171bn | +13.0% | −₩10.5bn margin −6.2% | ₩65.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
SD Biosensor top stories 2 weeks, by number of outlets
- 1
- 2
Latest SD Biosensor news Korean headlines
-
에스디바이오센서, 말라리아 이중 타깃 진단제품 공개…아프리카 공략 확대
1 more on this story · 1 outlets
- 에스디바이오센서, 차세대 말라리아 진단키트 공개…아프리카 공략 확대쿠키뉴스 · Sep 17 17:48
-
에스디바이오센서, ‘WHX Nairobi 2026’서 차세대 말라리아 진단 솔루션 공개
1 more on this story · 1 outlets
- "아프리카 시장 공략"⋯에스디바이오센서, 차세대 말라리아 진단 솔루션 공개아이뉴스24 · Sep 17 15:02
-
에스디바이오센서, '2026 대한민국 일자리 으뜸기업' 선정
3 more on this story · 3 outlets
- 에스디바이오센서, ‘2026 대한민국 일자리 으뜸기업’ 선정더바이오 · Sep 14 10:15
- 에스디바이오센서, '2026 일자리 으뜸기업' 선정팜뉴스 · Sep 14 14:00
- 에스디바이오센서, ‘대한민국 일자리 으뜸기업’ 선정라포르시안 · Sep 14 15:09